Maynard Um
-
-
-
-
-
-
-
Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $34 at H.C. Wainwright
-
-
-
-
-
-
-
FDA accepts Arcutis application to expand ZORYVE cream to children ages 2-5
-
-
-
-
-
-
-
Arcutis presents new ZORYVE data on sleep quality and long-term control
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Arcutis Biotherapeutics Inc. (ARQT)
-
-
-
-
-
-
-
Arcutis Biotherapeutics (ARQT) and Padagis Agree to Stay Patent Lawsuit
-
-
-
-
-
-
-
Arcutis Biotherapeutics Inc. (ARQT) PT Raised to $20 at Mizuho, Top Pick
-
-
-
-
-
-
-
Mizuho Reiterates Outperform Rating on Arcutis Biotherapeutics Inc. (ARQT)
-
404,873 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

